ESMO Calls for Oncology-Specific Safeguards in the EU Critical Medicines Act By Ogkologos - June 11, 2025 598 0 Facebook Twitter Google+ Pinterest WhatsApp Ensuring equitable access to cancer treatments remains central to EU health security efforts Source RELATED ARTICLESMORE FROM AUTHOR Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation in Patients with TP53 Y220C-mutated Solid Tumours Rare Disease Day 2026: Advancing equity for people living with rare cancers in Europe EMA Recommends Extension of Therapeutic Indications for Ponatinib MOST POPULAR Here’s Why We’re Building Pet-Friendly Domestic Violence Shelters–And How You Can... October 18, 2021 Can Chemotherapy Drugs Be Designed to Avoid Side Effects? December 16, 2022 Cancer in My Community: Advancements in Cancer Care in Singapore December 2, 2021 Nivolumab Plus Low-Dose Ipilimumab Demonstrates Clinical Benefit in First-Line Treatment for... October 20, 2021 Load more HOT NEWS 5 ways cancer can impact sexual wellbeing Liquid Biopsies for Cancer: What to Know and What to Expect ESMO awards its first fellowship to support digital and computational pathology New on NCI Websites for July 2019
